Modest protective effects of isoflavones from a red clover-derived dietary supplement on cardiovascular disease risk factors in perimenopausal women, and evidence of an interaction with ApoE genotype in 49-65 year-old women

Journal of Nutrition

Volumn 134, Issue 7, 2004, Pages 1759-1764

  Atkinson, Charlotte ^a   Oosthuizen, Welma ^b   Scollen, Serena ^c   Loktionov, Alexandre ^c   Day, Nicholas E ^a   Bingham, Sheila A ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NORTH WEST UNIVERSITY   (South Africa)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

ApoE; Cardiovascular disease; Isoflavone; Phytoestrogen; Randomized controlled trial

Indexed keywords

APOLIPOPROTEIN E; BIOCHANIN A; CHOLESTEROL; DAIDZEIN; FIBRINOGEN; FORMONONETIN; GENISTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE DERIVATIVE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLASMINOGEN ACTIVATOR INHIBITOR 1; SOYBEAN PROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GENOTYPE; GROUPS BY AGE; HEART PROTECTION; HUMAN; LIPID BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RED CLOVER; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

GLYCINE MAX; POMACANTHUS MACULOSUS; TRIFOLIUM; TRIFOLIUM PRATENSE;

EID: 3042698753     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.7.1759     Document Type: Article

References (62)

1. Holme, I. (1990) An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 82: 1916-1924.
2. Meeker, D. R. & Kesten, H. D. (1941) Effect of high protein diets on experimental atherosclerosis of rabbits. Arch. Pathol. 31: 147-162.
3. Anderson, J. W., Johnstone, B. M. & Cook-Newell, M. E. (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 333: 276-282.
4. Reinli, K. & Block, G. (1996) Phytoestrogen content of foods-a compendium of literature values. Nutr. Cancer 26: 123-148.
5. Anthony, M. S., Clarkson, T. B., Hughes, C. L., Jr., Morgan, T. M. & Burke, G. L. (1996) Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys, J. Nutr. 126: 43-50.
6. Anthony, M. S., Clarkson, T. B., Bullock, B. C. & Wagner, J. D. (1997) Soy protein versus soy phytoestrogens in the prevention of diet-induced coronary artery atherosclerosis of male cynomolgus monkeys. Arterioscler. Thromb. Vasc. Biol. 17: 2524-2531,
7. Ni, W., Yoshida, S., Tsuda, Y., Nagao, K. Sato, M. & Imaizumi, K. (1999) Ethanol-extracted soy protein isolate results in elevation of serum cholesterol in exogenously hypercholesterolemic rats. Lipids 34: 713-716.
8. Greaves, K. A., Parks, J. S., Williams, J. K. & Wagner, J. D. (1999) Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys. J. Nutr. 129: 1585-1592.
9. Greaves, K. A., Wilson, M. D., Rudel, L. L., Williams, J. K. & Wagner, J. D. (2000) Consumption of soy protein reduces cholesterol absorption compared to casein protein alone or supplemented with an isoflavone extract or conjugated equine estrogen in ovariectomized cynomolgus monkeys. J. Nutr. 130: 820-826.
10. Crouse, J. R., 3rd, Morgan, T., Terry, J. G., Ellis, J., Vitolins, M. & Burke, G. L. (1999) A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159: 2070-2076.
11. Mackey, R., Ekangaki, A. & Eden, J. A. (2000) The effects of soy protein in women and men with elevated plasma lipids. Biofactors 12: 251-257.
12. Clifton-Bligh, P. B., Baber, R. J., Fulcher, G. R., Nery, M. L. & Moreton, T. (2001) The effect of isoflavones extracted from red clover (Rimostil) on lipid and bone metabolism. Menopause 8: 259-265.
13. Howes, J. B., Sullivan, D., Lai, N., Nestel, P., Pomeroy, S., West, L., Eden, J. A. & Howes, L. G. (2000) The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152: 143-147.
14. Uesugi, T., Fukui, Y. & Yamori, Y. (2002) Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women: a four-week study. J. Am. Coll. Nutr. 21: 97-102.
15. Simons, L. A., von Konigsmark, M., Simons, J. & Celermajer, D. S. (2000) Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women. Am. J. Cardiol. 85: 1297-1301.
16. Dewell, A., Hollenbeck, C. B. & Bruce, B. (2002) The effects of soy-derived phytoestrogens on serum lipids and lipoproteins in moderately hypercholesterolemic postmenopausal women. J. Clin. Endocrinol. Metab. 87: 118-121.
17. Hsu, C. S., Shen, W. W., Hsueh, Y. M. & Yeh, S. L. (2001) Soy isoflavone supplementation in postmenopausal women. Effects on plasma lipids, antioxidant enzyme activities and bone density. J. Reprod. Med. 46: 221-226.
18. Samman, S., Lyons Wall, P. M., Chan, G. S., Smith, S. J. & Petocz, P. (1999) The effect of supplementation with isoflavones on plasma lipids and oxidisability of low density lipoprotein in premenopausal women. Atherosclerosis 147: 277-283.
19. Rivas, M., Garay, R. P., Escanero, J. F., Cia, P., Jr., Cia, P. & Alda, J. O. (2002) Soy milk lowers blood pressure in men and women with mild to moderate essential hypertension. J. Nutr. 132: 1900-1902.
20. Teede, H. J., Dalais, F. S., Kotsopoulos, D., Liang, Y. L., Davis, S. & McGrath, B. P. (2001) Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J. Clin. Endocrinol. Metab. 86: 3053-3060.
21. Washburn, S., Burke, G. L., Morgan, T. & Anthony, M. (1999) Effect of soy protein supplementation on serum lipoproteins, blood pressure, and menopausal symptoms in perimenopausal women. Menopause 6: 7-13.
22. Jenkins, D. J., Kendall, C. W., Jackson, C. J., Connelly, P. W., Parker, T., Faulkner, D., Vidgen, E., Cunnane, S. C., Leiter, L. A. & Josse, R. G. (2002) Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clin. Nutr. 76: 365-372.
23. Ernst, E. & Resch, K. L. (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med. 118: 956-963.
24. Koenig, W. (1999) Fibrinogen and coronary risk. Curr. Cardiol. Rep. 1: 112-118.
25. Olofsson, B. O., Dahlen, G. & Nilsson, T. K. (1989) Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease. Eur. Heart J. 10: 77-82.
26. Nordt, T. K., Peter, K., Ruef, J., Kubler, W. & Bode, C. (1999) Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease. Thromb. Haemost. 82: 14-18.
27. Kohler, H. P. & Grant, P. J. (2000) Plasminogen-activator inhibitor type 1 and coronary artery disease. N. Engl. J. Med. 342: 1792-1801.
28. Ashton, E. L., Dalais, F. S. & Ball, M. J. (2000) Effect of meat replacement by tofu on CHD risk factors including copper induced LDL oxidation. J. Am. Coll. Nutr. 19: 761-767.
29. Dent, S. B., Peterson, C. T., Brace, L. D., Swain, J. H., Reddy, M. B., Hanson, K. B., Robinson, J. G. & Alekel, D. L. (2001) Soy protein intake by perimenopausal women does not affect circulating lipids and lipoproteins or coagulation and fibrinolytic factors. J. Nutr. 131: 2280-2287.
30. Hermansen, K., Sondergaard, M., Hoie, L., Carstensen, M. & Brock, B. (2001) Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24: 228-233.
31. Sanders, T. A., Dean, T. S., Grainger, D., Miller, G. J. & Wiseman, H. (2002) Moderate intakes of intact soy protein rich in isoflavones compared with ethanol-extracted soy protein increase HDL but do not influence transforming growth factor beta(1) concentrations and hemostatic risk factors for coronary heart disease in healthy subjects. Am. J. Clin. Nutr. 76: 373-377.
32. Mahley, R. W. & Rall, S. C., Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. 1: 507-537.
33. Wolfe, J. N. (1976) Breast patterns as an index of risk for developing breast cancer. Am. J. Roentgenol. 126: 1130-1137.
34. Atkinson, C., Compston, J. E., Day, N. E., Dowsett, M. & Bingham, S. A. (2004) The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 79: 326-333.
35. Setchell, K. D., Brown, N. M., Desai, P., Zimmer-Nechemias, L., Wolfe, B. E., Brashear, W. T., Kirschner, A. S., Cassidy, A. & Heubi, J. E. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J. Nutr. 131: 1362S-1375S.
36. Bingham, S. & Cummings, J. H. (1983) The use of 4-aminobenzoic acid as a marker to validate the completeness of 24 h urine collections in man. Clin. Sci. (Lond.) 64: 629-635.
37. Johansson, G., Bingham, S. & Vahter, M. (1999) A method to compensate for incomplete 24-hour urine collections in nutritional epidemiology studies. Public Health Nutr. 2: 587-591.
38. Setchell, K. D., Welsh, M. B. & Lim, C. K. (1987) High-performance liquid chromatographic analysis of phytoestrogens in soy protein preparations with ultraviolet, electrochemical and thermospray mass spectrometric detection. J. Chromatogr. 386: 315-323.
39. Franke, A. A., Custer, L. J., Cerna, C. M. & Narala, K. (1995) Rapid HPLC analysis of dietary phytoestrogens from legumes and from human urine. Proc. Soc. Exp. Biol. Med. 208: 18-26.
40. von Clauss, A. (1957) Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens. Acta Haematol. 17: 237-246.
41. Friedewald, W. T., Levy, R. I. & Fredrickson, D. S. (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
42. Dowsett, M., Goss, P. E., Powles, T. J., Hutchinson, G., Brodie, A. M., Jeffcoate, S. L. & Coombes, R. C. (1987) Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route. Cancer Res. 47: 1957-1961.
43. Loktionov, A., Bingham, S. A., Vorster, H., Jerling, J. C., Runswick, S. A. & Cummings, J. H. (1998) Apolipoprotein E genotype modulates the effect of black tea drinking on blood lipids and blood coagulation factors: a pilot study. Br. J. Nutr. 79: 133-139.
44. Gooderham, M. H., Adlercreutz, H., Ojala, S. T., Wahala, K. & Holub, B. J. (1996) A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J. Nutr. 126: 2000-2006.
45. Hodgson, J. M., Puddey, I. B., Beilin, L. J., Mori, T. A. & Croft, K. D. (1998) Supplementation with isoflavonoid phytoestrogens does not alter serum lipid concentrations: a randomized controlled trial in humans. J. Nutr. 128: 728-732.
46. Merz-Demlow, B. E., Duncan, A. M., Wangen, K. E., Xu, X., Carr, T. P., Phipps, W. R. & Kurzer, M. S. (2000) Soy isoflavones improve plasma lipids in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 71: 1462-1469.
47. Takatsuka, N., Nagata, C., Kurisu, Y., Inaba, S., Kawakami, N. & Shimizu, H. (2000) Hypocholesterolemic effect of soymilk supplementation with usual diet in premenopausal normolipidemic Japanese women. Prev. Med. 31: 308-314.
48. Hokanson, J. E. (2002) Hypertriglyceridemia and risk of coronary heart disease. Curr. Cardiol. Rep. 4: 488-493.
49. Knopp, R. H. (2002) Risk factors for coronary artery disease in women. Am. J. Cardiol. 89: 28E-34E.
50. Forrester, J. S. (2001) Triglycerides: risk factor or fellow traveler? Curr. Opin. Cardiol. 16: 261-264.
51. Bruschi, F., Meschia, M., Soma, M., Perotti, D., Paoletti, R. & Crosignani, P. G. (1996) Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet. Gynecol. 88: 950-954.
52. Stefanick, M. L. (1999) Estrogen, progestogens and cardiovascular risk. J. Reprod. Med. 44: 221-226.
53. Yildirir, A., Tokgozoglu, S. L., Oduncu, T., Oto, A., Haznedaroglu, I., Akinci, D., Koksal, G., Sade, E., Kirazli, S. & Kes, S. (2001) Soy protein diet significantly improves endothelial function and lipid parameters. Clin. Cardiol. 24: 711-716.
54. Dalais, F. S., Ebeling, P. R., Kotsopoulos, D., McGrath, B. P. & Teede, H. J. (2003) The effects of soy protein containing isoflavones on lipids and indices of bone resorption in postmenopausal women. Clin. Endocrinol. 58: 704-709.
55. Blakesmith, S. J., Lyons-Wall, P. M., George, C., Joannou, G. E., Petocz, P. & Samman, S. (2003) Effects of supplementation with purified red clover (Trifolium pratense) isoflavones on plasma lipids and insulin resistance in healthy premenopausal women. Br. J. Nutr. 89: 467-474.
56. Potter, S. M. (1998) Soy protein and cardiovascular disease: the impact of bioactive components in soy. Nutr. Rev. 56: 231-235.
57. Dammerman, M. & Breslow, J. L. (1995) Genetic basis of lipoprotein disorders. Circulation 91: 505-512.
58. Mahley, R. W. & Rall, S. C. (1989) Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: The Metabolic Basics of Inherited Disease (Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D., eds.), pp. 1195-1213. McGraw-Hill, New York, NY.
59. Wilson, P. W., Myers, R. H., Larson, M. G., Ordovas, J. M., Wolf, P. A. & Schaefer, E. J. (1994) Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study. J. Am. Med. Assoc. 272: 1666-1671.
60. Heikkinen, A. M., Niskanen, L., Ryynanen, M., Komulainen, M. H., Tuppurainen, M. T., Parviainen, M. & Saarikoski, S. (1999) Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by apoE genotype? Arterioscler. Thromb. Vasc. Biol. 19: 402-407.
61. Gaddi, A., Ciarrocchi, A., Matteucci, A., Rimondi, S., Ravaglia, G., Descovich, G. C. & Sirtori, C. R. (1991) Dietary treatment for familial hypercholesterolemia-differential effects of dietary soy protein according to the apolipoprotein E phenotypes. Am. J. Clin. Nutr. 53: 1191-1196.
62. Vigna, G. B., Pansini, F., Bonaccorsi, G., Albertazzi, P., Donega, P., Zanotti, L., De Aloysio, D., Mollica, G. & Fellin, R. (2000) Plasma lipoproteins in soy-treated postmenopausal women: a double-blind, placebo-controlled trial. Nutr. Metab. Cardiovasc. Dis. 10: 315-322.